These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3099492)

  • 21. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine babesiosis: protection of cattle with culture-derived soluble Babesia bovis antigen.
    Smith RD; James MA; Ristic M; Aikawa M; Vega y Murguia CA
    Science; 1981 Apr; 212(4492):335-8. PubMed ID: 7209532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Babesia bovis: dextran sulphate as an adjuvant for and precipitant of protective immunogens.
    Goodger BV; Waltisbuhl DJ; Commins MA; Wright IG
    Int J Parasitol; 1992 Jul; 22(4):465-9. PubMed ID: 1644521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Babesia bovis: the effect of acute inflammation and isoantibody production in the detection of babesial antigens.
    Goodger BV; Wright IG; Waltisbuhl DJ
    Experientia; 1985 Dec; 41(12):1577-9. PubMed ID: 4076403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
    Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
    Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.
    Schetters TP; Moubri K; Cooke BM
    J S Afr Vet Assoc; 2009 Jun; 80(2):75-8. PubMed ID: 19831266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitigation of the response of Friesian calves to live Babesia bovis vaccine by treatment with long acting oxytetracycline.
    Pipano E; Krigel Y; Markovics A; Rubinstein E; Frank M
    Vet Rec; 1985 Oct; 117(16):413-4. PubMed ID: 4071930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Babesia bigemina: immunization with purified rhoptries induces protection against acute parasitemia.
    Machado RZ; McElwain TF; Pancracio HP; Freschi CR; Palmer GH
    Exp Parasitol; 1999 Oct; 93(2):105-8. PubMed ID: 10502474
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Babesia bovis: immunity induced by vaccination with a lipid enriched fraction.
    Goodger BV; Commins MA; Waltisbuhl DJ; Wright IG; Rode-Bramanis K
    Int J Parasitol; 1990 Aug; 20(5):685-7. PubMed ID: 2228430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
    Brown WC
    Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.
    Valentin A; Precigout E; L'Hostis M; Carcy B; Gorenflot A; Schrevel J
    Infect Immun; 1993 Feb; 61(2):734-41. PubMed ID: 8423099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.